Talk:Annelies Wilder-Smith
| This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||
| ||||||||
Sources: Google Scholar and more
[edit]She has a Google Scholar profile. GS is not always right, and in fact the first contribution attributed to her is possibly an error (WHO Guidelines for the treatment of malaria). But the second one is a (very) short review article on the basic reproduction number of COVID-19 (SARS-2) which was published as early as 13 February 2020. She had some more early and well-recognized contributions on COVID-19 epidemiology (especially containment and mitigation). Some of her most-cited papers in the time before 2020 were about dengue. --Himbeerbläuling (talk) 18:11, 31 October 2020 (UTC)
- A first glance of her wide-range research areas of interest can be found in Heidelberg Institute of Global Health website: Year 2012, publications no. 7—18 (if you count them manually) are hers. Many of them deal with dengue, but from very (very!) different points of view. --Himbeerbläuling (talk) 21:21, 31 October 2020 (UTC)
no place of birth?
[edit]no such thing wanted? — Preceding unsigned comment added by 80.108.129.198 (talk) 10:32, 16 June 2021 (UTC)